Sinusoidal Obstruction Syndrome
12
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
8%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (12)
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Defibrotide Dose-escalation for SOS Post-HSCT
Detection of Sinusoidal Obstruction Syndrome With Ultrasound After Allogeneic HSCT
Ultrasound Elastography to Predict Development of SOS
Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India
Using Ultrasound Elastography to Predict Development of SOS
Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study
Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY)
5-day Defibrotide Treatment for Hepatic SOS/VOD
Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients
Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants